Impact of Prostate-specific Antigen on a Baseline Prostate Cancer Risk Assessment Including Genetic Risk REPLY

被引:0
|
作者
Kader, A. Karim [1 ]
Liss, Michael A. [1 ]
Xu, Jianfeng [2 ,3 ]
Fleshner, Neil E. [4 ]
机构
[1] Univ Calif San Diego, Div Urol, San Diego, CA 92103 USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Dept Genom, Winston Salem, NC USA
[3] Wake Forest Univ, Bowman Gray Sch Med, Dept Personalized Med Res, Winston Salem, NC USA
[4] Univ Hlth Network, Div Urol, Dept Surg, Toronto, ON, Canada
关键词
D O I
10.1016/j.urology.2014.07.083
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:171 / 171
页数:1
相关论文
共 50 条
  • [1] Impact of Prostate-specific Antigen on a Baseline Prostate Cancer Risk Assessment Including Genetic Risk
    Kader, A. Karim
    Liss, Michael A.
    Trottier, Greg
    Kim, Seong-Tae
    Sun, Jielin
    Zheng, S. Lilly
    Chadwick, Karen
    Lockwood, Gina
    Xu, Jianfeng
    Fleshner, Neil E.
    [J]. UROLOGY, 2015, 85 (01) : 165 - 170
  • [2] Impact of Prostate-specific Antigen on a Baseline Prostate Cancer Risk Assessment Including Genetic Risk EDITORIAL COMMENT
    Loeb, Stacy
    [J]. UROLOGY, 2015, 85 (01) : 170 - 171
  • [3] Reply to “Variation in KLK genes, prostate-specific antigen and risk of prostate cancer”
    Rosalind Eeles
    Graham Giles
    David Neal
    Kenneth Muir
    Douglas F Easton
    [J]. Nature Genetics, 2008, 40 : 1035 - 1036
  • [4] Variation in KLK genes, prostate-specific antigen and risk of prostate cancer -: Reply
    Eeles, Rosalind
    Giles, Graham
    Neal, David
    Muir, Kenneth
    Easton, Douglas F.
    [J]. NATURE GENETICS, 2008, 40 (09) : 1035 - 1036
  • [5] Baseline prostate-specific antigen level and risk of prostate cancer and prostate-specific mortality: Diagnosis is dependent on the intensity of investigation
    Connolly, David
    Black, Amanda
    Gavin, Anna
    Keane, Patrick F.
    Murray, Liam J.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (02) : 271 - 278
  • [6] Prostate-specific antigen gene polymorphism and prostate cancer risk
    Sivonova, M.
    Matakova, T.
    Dobrota, D.
    Hatok, J.
    Kliment, J., Jr.
    Tomaskin, R.
    Kliment, J.
    [J]. EJC SUPPLEMENTS, 2008, 6 (03): : 53 - 54
  • [7] Genetic polymorphism in the androgen receptor and prostate-specific antigen genes and prostate cancer risk
    Salinas, CA
    Langlois, M
    Iwasaki, L
    Ostrander, EA
    Stanford, JL
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 240 - 240
  • [8] BASELINE PROSTATE SPECIFIC ANTIGEN LEVEL AND THE RISK OF PROSTATE CANCER AND PROSTATE SPECIFIC MORTALITY
    Connolly, D.
    Black, A.
    Van Leeuwen, P. J.
    Gavin, A.
    Murray, L. J.
    Keane, P. F.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 164 - 164
  • [9] Baseline prostate specific antigen level and the risk of prostate cancer and prostate specific mortality
    Connolly, D. J.
    Black, A.
    Van Leeuwen, P. V.
    Gavin, A.
    Murray, L. J.
    Keane, P. F.
    [J]. BJU INTERNATIONAL, 2009, 103 : 12 - 12
  • [10] Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort
    Larsen, Signe Benzon
    Brasso, Klaus
    Iversen, Peter
    Christensen, Jane
    Christiansen, Michael
    Carlsson, Sigrid
    Lilja, Hans
    Friis, Soren
    Tjonneland, Anne
    Dalton, Susanne Oksbjerg
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (14) : 3041 - 3048